BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19201190)

  • 1. 4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production.
    Mitchell L; Wang Z; Hu LY; Kostlan C; Carroll M; Dettling D; Du D; Pocalyko D; Wade K
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1310-3. PubMed ID: 19201190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphenyl ethers as androgen receptor antagonists for the topical suppression of sebum production.
    Mitchell LH; Hu LY; Nguyen M; Fakhoury S; Smith Y; Iula D; Kostlan C; Carroll M; Dettling D; Du D; Pocalyko D; Wade K; Lefker B
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2176-8. PubMed ID: 19286380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production.
    Van Camp JA; Hu LY; Kostlan C; Lefker B; Li J; Mitchell L; Wang Z; Yue WS; Carroll M; Dettling D; Du D; Pocalyko D; Wade K
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5529-32. PubMed ID: 17764935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production.
    Hu LY; Du D; Hoffman J; Smith Y; Fedij V; Kostlan C; Johnson TR; Huang Y; Kesten S; Harter W; Yue WS; Li JJ; Barvian N; Mitchell L; Lei HJ; Lefker B; Carroll M; Dettling D; Krieger-Burke T; Samas B; Yalamanchili R; Lapham K; Pocalyko D; Sliskovic D; Ciotti S; Stoller B; Hena MA; Ding Q; Maiti SN; Stier M; Welgus H
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5983-8. PubMed ID: 17827000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantolactams as androgen receptor antagonists for the topical suppression of sebum production.
    Sexton KE; Barrett S; Bridgwood K; Carroll M; Dettling D; Du D; Fakhoury S; Fedij V; Hu LY; Kostlan C; Pocalyko D; Raheja N; Smith Y; Shanmugasundaram V; Wade K
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5230-3. PubMed ID: 21831636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of a topical androgen receptor antagonist for the suppression of sebum production with properties suitable for follicular delivery.
    Mitchell LH; Johnson TR; Lu GW; Du D; Datta K; Grzemski F; Shanmugasundaram V; Spence J; Wade K; Wang Z; Sun K; Lin K; Hu LY; Sexton K; Raheja N; Kostlan C; Pocalyko D
    J Med Chem; 2010 Jun; 53(11):4422-7. PubMed ID: 20462217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production.
    Hu LY; Lei HJ; Du D; Johnson TR; Fedij V; Kostlan C; Yue WS; Lovdahl M; Li JJ; Carroll M; Dettling D; Asbill J; Fan C; Wade K; Pocalyko D; Lapham K; Yalamanchili R; Samas B; Vrieze D; Ciotti S; Krieger-Burke T; Sliskovic D; Welgus H
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5693-7. PubMed ID: 17766112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications.
    Li JJ; Iula DM; Nguyen MN; Hu LY; Dettling D; Johnson TR; Du DY; Shanmugasundaram V; Van Camp JA; Wang Z; Harter WG; Yue WS; Boys ML; Wade KJ; Drummond EM; Samas BM; Lefker BA; Hoge GS; Lovdahl MJ; Asbill J; Carroll M; Meade MA; Ciotti SM; Krieger-Burke T
    J Med Chem; 2008 Nov; 51(21):7010-4. PubMed ID: 18921992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening.
    Lanter JC; Fiordeliso JJ; Jiang W; Allan GF; Lai MT; Linton O; Hahn do W; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):123-6. PubMed ID: 17071085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
    van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands.
    Wakabayashi K; Miyachi H; Hashimoto Y; Tanatani A
    Bioorg Med Chem; 2005 Apr; 13(8):2837-46. PubMed ID: 15781394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative binding affinity at metribolone androgenic binding sites of various antiandrogenic agents.
    Luderschmidt C; Jawny J; Eiermann W
    Arzneimittelforschung; 1987 Nov; 37(11):1262-5. PubMed ID: 3501955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists.
    Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Feb; 17(4):955-8. PubMed ID: 17134895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists.
    Xiao HY; Balog A; Attar RM; Fairfax D; Fleming LB; Holst CL; Martin GS; Rossiter LM; Chen J; Cvjic ME; Dell-John J; Geng J; Gottardis MM; Han WC; Nation A; Obermeier M; Rizzo CA; Schweizer L; Spires T; Shan W; Gavai A; Salvati ME; Vite G
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4491-5. PubMed ID: 20584610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new class of androgen receptor antagonists bearing carborane in place of a steroidal skeleton.
    Fujii S; Hashimoto Y; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem Lett; 2005 Jan; 15(1):227-30. PubMed ID: 15582444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic and binding activities of 5 alpha-reductase and androgen receptors in hamster prostate.
    Cabeza M; Bratoeff E; Heuze I; Ramírez E; Sánchez M; Flores E
    Proc West Pharmacol Soc; 2003; 46():128-31. PubMed ID: 14699908
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors.
    Schneider J; Kneip C; Jahnel U
    Pharmacology; 2009; 84(2):74-81. PubMed ID: 19590256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative binding affinity of novel steroids to androgen receptors in hamster prostate.
    Cabeza M; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Rojas A; Orozco A; Mungía A; Agustín G; Cuatepotzo L; Gonzalez C; Palma S; Padilla D; Perez V; Jimenez G
    J Enzyme Inhib Med Chem; 2005 Aug; 20(4):357-64. PubMed ID: 16206830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
    Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.